Latest Boardroom Shifts News

Lord Resources announces the resignation of CEO Andrew Taylor as exploration at the Ilgarari Copper Project advances under Georgina Clark’s management.

Aguia Resources reported steady progress in its June 2025 quarter, highlighting underground gold production in Colombia and development milestones in Brazil’s phosphate project, alongside strategic capital raises and operational restructuring.

InteliCare Holdings advances its AI-driven aged care platform with new trials and integrations, secures $1 million in funding, and announces CEO Daniel Pilbrow’s upcoming resignation.

Belararox Limited reports promising broad copper mineralisation from Phase 1 drilling at its TMT Project in Argentina and significant exploration progress in Botswana’s Kalahari Copper Belt, supported by a strong cash position and strategic board changes.

FirstWave Cloud Technology reports a slight revenue decline in Q4 FY25, offsets challenges with strategic restructuring and a new AWS marketplace partnership.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

Winchester Energy Limited has resumed trading on the ASX following confirmation that it now meets director requirements under the Corporations Act. This development ends a trading suspension tied to governance compliance.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

Janus Electric Holdings has relaunched on the ASX, securing $8.8 million to accelerate its heavy vehicle electrification strategy, including a key supply agreement with Electrovaya for next-generation lithium-ion batteries.

Odessa Minerals reports encouraging base metal anomalies and uranium exploration progress at its Lyndon Project, alongside strategic board changes and ongoing acquisition reviews.

American Rare Earths Limited reports strong progress at its Halleck Creek Rare Earths Project, highlighted by exceptional sampling results, key permitting milestones, and a $15 million equity raise to fund development.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.